KFDA recommends not to use dibutylphthalate

Published: 2009-12-31 07:00:00
Updated: 2009-12-31 07:00:00
The Korea Food and Drug Administration has recently instructed pharmaceutical firms to replace dibutylphthalate (DBP) owing to the possible risk of adverse reactions.

Manufacturers of 37 medicines containing DBP as a pharmaceutical excipient, such as Boehringer Ingelheim’s Dulcolax, will be ob...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.